Pharmacokinetics and Bioavailability of Granisetron Hydrochloride Tablets in Healthy Volunteers
Zhong Li-li
Abstract
Zhong Li-li
Abstract
The pharmacokinetics of granisetron hydrochloride orally disintegrating tablets (test preparation) and its related bioavailability to granisetron hydrochloride tablets (reference preparation) are discussed. According a single dose crossover design,20 healthy volunteers were administrated with 1mg of test and reference preparations. The plasma concentrations were determined by HPLC-fluorescence detector. The pharmacokinetic parameters of the test and reference preparations were as follows:cmax (3.32±0.93) and (3.20±0.86) ng/ml,tmax (1.65±0.52) and (1.88±0.86) h,t1/2 (6.16±0.90) and (6.22±0.81) h,AUC0→t (19.50±8.10) and (19.70±7.78) ng·h·ml-1,AUC0→∞ (20.90±9.11) and (21.10± 8.57) ng·h·ml-1. The relative bioavailability of the test preparation was (99.8±15.3)%. The result showed that the two preparations were bioequivalent.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The pharmacokinetics of granisetron hydrochloride orally disintegrating tablets (test preparation) and its related bioavailability to granisetron hydrochloride tablets (reference preparation) are discussed. According a single dose crossover design,20 healthy volunteers were administrated with 1mg of test and reference preparations. The plasma concentrations were determined by HPLC-fluorescence detector. The pharmacokinetic parameters of the test and reference preparations were as follows:cmax (3.32±0.93) and (3.20±0.86) ng/ml,tmax (1.65±0.52) and (1.88±0.86) h,t1/2 (6.16±0.90) and (6.22±0.81) h,AUC0→t (19.50±8.10) and (19.70±7.78) ng·h·ml-1,AUC0→∞ (20.90±9.11) and (21.10± 8.57) ng·h·ml-1. The relative bioavailability of the test preparation was (99.8±15.3)%. The result showed that the two preparations were bioequivalent.
Key concepts: Bioequivalence, Bioavailability, Pharmacokinetics, Chemistry, Cmax, Pharmacology, Granisetron, High-performance liquid chromatography